✦ LIBER ✦

Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure

✍ Scribed by Shiro Miwa; Yasuhiko Hashikura; Atsuyoshi Mita; Tatsuya Kubota; Hisanao Chisuwa; Yuichi Nakazawa; Toshihiko Ikegami; Masaru Terada; Shinichi Miyagawa; Seiji Kawasaki

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 80 KB
Volume: 30
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510300621

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver transplantation in patients with f

Liver transplantation in patients with fulminant hepatic failure

✍ Professor E. Moreno González; G. I. García; S. C. Loinaz; S. R. Gómez; I. Gonzál 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

Living unrelated liver transplantation b

✍ Dr C. M. Lo; P. Gertsch; S. T. Fan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Transplantation for fulminant and subful

Transplantation for fulminant and subfulminant hepatic failure with preservation of portal and caval flow

✍ Dr J. Belghiti; R. Noun; A. Sauvanet; F. Durand; J. Aschehoug; S. Erlinger; J. P 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

Liver transplantation for fulminant hepa

Liver transplantation for fulminant hepatic failure and late-onset hepatic failure in children

✍ Mr K. C. Tan; R. S. Mondragon; V. Vougas; G. Mieli-Vergani; N. D. Heaton; A. P. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Prediction of survival for patients with

Prediction of survival for patients with fulminant hepatic failure

✍ James Neuberger 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Antituberculous therapy–induced fulminan

Antituberculous therapy–induced fulminant hepatic failure: Successful treatment with liver transplantation and nonstandard antituberculous therapy

✍ Ramazan Idilman; Sadik Ersoz; Sahin Coban; Ozlem Kumbasar; Hakan Bozkaya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Standard antituberculous therapy including isoniazid, rifampin, ethambutol, and pyrazinamide is widely used for the treatment of active tuberculosis. Its most important side effect is hepatotoxicity, ranging from asymptomatic transaminitis to fulminant hepatic failure. A 19-year-old woman was admitt